Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
16.12
-0.02 (-0.12%)
At close: Nov 21, 2024, 4:00 PM
16.20
+0.08 (0.50%)
After-hours: Nov 21, 2024, 6:04 PM EST
Pulse Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
56
Market Cap
991.65M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AMN Healthcare Services | 3.07B |
Collegium Pharmaceutical | 599.25M |
HealthStream | 287.99M |
Weave Communications | 195.84M |
Avadel Pharmaceuticals | 138.16M |
Vir Biotechnology | 78.62M |
Zymeworks | 62.20M |
PLSE News
- 21 days ago - Pulse Biosciences Announces Positive Clinical Data Presented at the American Thyroid Association - Business Wire
- 22 days ago - Pulse Biosciences, Inc. (PLSE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results - Business Wire
- 22 days ago - Pulse Biosciences Announces Appointment of David Kenigsberg, M.D. as Chief Medical Officer of Electrophysiology - Business Wire
- 4 weeks ago - Pulse Biosciences Schedules Third Quarter 2024 Financial Results Conference Call for October 30, 2024 - Business Wire
- 3 months ago - Pulse Biosciences Inc. (PLSE) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Pulse Biosciences Reports Business Updates and Preliminary Second Quarter 2024 Financial Results - Business Wire
- 3 months ago - Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Business Wire